Your browser doesn't support javascript.
loading
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer.
Liu, J F; Moore, K N; Birrer, M J; Berlin, S; Matulonis, U A; Infante, J R; Wolpin, B; Poon, K A; Firestein, R; Xu, J; Kahn, R; Wang, Y; Wood, K; Darbonne, W C; Lackner, M R; Kelley, S K; Lu, X; Choi, Y J; Maslyar, D; Humke, E W; Burris, H A.
Afiliação
  • Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston joyce_liu@dfci.harvard.edu.
  • Moore KN; Division of Gynecologic Oncology, Stephenson Oklahoma Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City.
  • Birrer MJ; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.
  • Berlin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.
  • Matulonis UA; Department of Oncology, New England Cancer Care Specialists, Kennebunk.
  • Infante JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.
  • Wolpin B; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville.
  • Poon KA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.
  • Firestein R; Early Development, Genentech, South San Francisco, USA.
  • Xu J; Early Development, Genentech, South San Francisco, USA.
  • Kahn R; Early Development, Genentech, South San Francisco, USA.
  • Wang Y; Early Development, Genentech, South San Francisco, USA.
  • Wood K; Early Development, Genentech, South San Francisco, USA.
  • Darbonne WC; Early Development, Genentech, South San Francisco, USA.
  • Lackner MR; Early Development, Genentech, South San Francisco, USA.
  • Kelley SK; Early Development, Genentech, South San Francisco, USA.
  • Lu X; Early Development, Genentech, South San Francisco, USA.
  • Choi YJ; Early Development, Genentech, South San Francisco, USA.
  • Maslyar D; Early Development, Genentech, South San Francisco, USA.
  • Humke EW; Early Development, Genentech, South San Francisco, USA.
  • Burris HA; Early Development, Genentech, South San Francisco, USA.
Ann Oncol ; 27(11): 2124-2130, 2016 11.
Article em En | MEDLINE | ID: mdl-27793850
Assuntos
Palavras-chave
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Pancreáticas / Anticorpos Anti-Idiotípicos / Imunoconjugados Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Pancreáticas / Anticorpos Anti-Idiotípicos / Imunoconjugados Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article